introduction: photobiostimulation with low level laser (lll) has been used in medicine for a long time and its effects have been shown in many diseases. some studies have evaluated the effect of lll on androgenic alopecia. one of the most important limitations of the use of lll in the treatment of alopecia is the requirement for multiple sessions, which is hardly accepted by patients. this stud...

Background: The association between coronary artery disease and androgenic alopecia has been demonstrated, but few studies have focused on the mechanism of this association. The aim of this study was to evaluate the lipid profile in male pattern alopecia.Methods: In this case control study, 45 male patients with androgenic alopecia who were aged from 20 to 50 years and 45 men with a norma...

UNLABELLED Platelet-rich plasma (PRP) has become a newer method for the treatment of various types of alopecia. In this prospective study, safety, efficacy and feasibility of PRP injections in treating androgenic alopecia were assessed. Eleven patients suffering from hair loss due to androgenic alopecia and not responding to 6 months treatment with minoxidil and finasteride were included in thi...

Alopecia can be either scarring or non-scarring. Non-scarring alopecias tend to have preserved follicular ostia, with no clinically visible inflammation in most presentations, although histologic inflammation may be present. The common types of non-scarring alopecias are androgenic alopecia, telogen effluvium, alopecia areata, trichotillomania and traction alopecia. Scarring alopecias, also kno...

BACKGROUND The pathogenesis of androgenic alopecia is not fully understood. A microbial-driven inflammatory reaction abutting on the hair follicles might participate in the hair status anomaly. OBJECTIVE The aim of our study was to determine if ketoconazole (KCZ) which is active against the scalp microflora and shows some intrinsic anti-inflammatory activity might improve alopecia. METHOD T...

Dihydrotestosterone(DHT) has played the pathogenic role in androgenetic alopecia. Patients with genetic deficiency of 5 alpha-reductase type II enzyme, which converts testosterone to DHT, do not have androgenic alopecia. The conversion of testosterone to DHT at hair follicles leads to miniaturization. In scalp biopsy, the tissue DHT level is significantly increased in balded area than non-balde...

Male pattern baldness or androgenic alopecia is a great problem for many individuals’ especially young people. A100 is composed of two active ingredients, a pollen extract and pentane-1,5-diol. The pollen extract provides a source of natural nutrients and pentane-1,5-diol acts as a solvent to unplug the hair follicle as well as acts as an enhancer for uptake of nutrients. Other components are c...

Th is s tudy has 2 aims. a) to fi nd ou t whether thc re are any possibi lities of early influencing malepatte rn Alopecia by topica! therapeutics in the sense of «ha ir maintenance». b) To dcfine easy perfo1·mable methods for its object ive measu remen l. A c linica! s tudy under cont ro lled double blind condit ions was done in 30 male volunteers (age 21-30) wilh mpa type I a nd II (Rook). Af...